Goat PRP14 (gPRP14) has xeno-antigenic properties and works as a vaccine in preclinical models of cancer.
S. Minucci, B. Bussolati, P. Massa, A. Brossa, R. Ravasio, M. Saadeldin, G. Degani, E. Papadimitriou, A. Saadeldin, A. Salvaggio, C. Visentin, G. Rizzi, S. Ricagno, L. Popolo, M. A. Vanoni, P. G. Pelicci
This study characterizes gPRP14 as a tumor-specific xeno-antigen that induces anti-tumor immunity in preclinical cancer models.
bioRxiv · Jul 4, 2022 · PreprintCancer Biology